155 related articles for article (PubMed ID: 36583266)
1. The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single Cell Analysis.
Yan H; Zhu J; Ping Y; Yan M; Liao G; Yuan H; Zhou Y; Xiang F; Pang B; Xu J; Pang L
Stem Cells; 2023 Mar; 41(2):111-125. PubMed ID: 36583266
[TBL] [Abstract][Full Text] [Related]
2. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
4. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
5. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
6. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
7. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
8. The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation.
Wang L; Babikir H; Müller S; Yagnik G; Shamardani K; Catalan F; Kohanbash G; Alvarado B; Di Lullo E; Kriegstein A; Shah S; Wadhwa H; Chang SM; Phillips JJ; Aghi MK; Diaz AA
Cancer Discov; 2019 Dec; 9(12):1708-1719. PubMed ID: 31554641
[TBL] [Abstract][Full Text] [Related]
9. Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.
Orzan F; De Bacco F; Crisafulli G; Pellegatta S; Mussolin B; Siravegna G; D'Ambrosio A; Comoglio PM; Finocchiaro G; Boccaccio C
Stem Cells; 2017 Nov; 35(11):2218-2228. PubMed ID: 28895245
[TBL] [Abstract][Full Text] [Related]
10. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X
Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841
[TBL] [Abstract][Full Text] [Related]
11. CSNK1D is associated with stemness and invasiveness in glioblastoma.
Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M
Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821
[TBL] [Abstract][Full Text] [Related]
12. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
13. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
[TBL] [Abstract][Full Text] [Related]
14. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
[TBL] [Abstract][Full Text] [Related]
15. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
16. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
[TBL] [Abstract][Full Text] [Related]
17. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
Biserova K; Jakovlevs A; Uljanovs R; Strumfa I
Cells; 2021 Mar; 10(3):. PubMed ID: 33799798
[TBL] [Abstract][Full Text] [Related]
19. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
